Exposure to secondhand smoke outside of a bar and a restaurant and tobacco exposure biomarkers in nonsmokers

Environmental Health Perspectives

Volumn 120, Issue 7, 2012, Pages 1010-1016

  St Helen, Gideon ^a   Thomas Bernert, J ^b   Hall, Daniel B ^a   Sosnoff, Connie S ^b   Xia, Yang ^b   Balmes, John R ^c   Vena, John E ^a   Wang, Jia Sheng ^a   Holland, Nina T ^d   Naeher, Luke P ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

NNAL; Outdoor secondhand smoke; Salivary cotinine; Smoking bans; Tobacco nitrosamines

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; BIOLOGICAL MARKER; COTININE; CREATININE;

ADULT; AIR QUALITY; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CROSSOVER PROCEDURE; EXPOSURE; FEMALE; HEALTH HAZARD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; MALE; NORMAL HUMAN; PASSIVE SMOKING; PRIORITY JOURNAL; SALIVA ANALYSIS; TANDEM MASS SPECTROMETRY; TOBACCO; URINALYSIS;

BIOLOGICAL MARKERS; CROSS-OVER STUDIES; ENVIRONMENTAL MONITORING; GEORGIA; HUMANS; NICOTINE; NITROSAMINES; PYRIDINES; RESTAURANTS; SALIVA; SMOKING; TOBACCO SMOKE POLLUTION;

NICOTIANA TABACUM;

EID: 84864526883     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104413     Document Type: Article

References (35)

1. Anderson KE, Carmella SG, Ye M, Bliss RL, Le C, Murphy L, et al. 2001. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke. J Natl Cancer Inst 93(5):378-381.
2. Anderson KE, Kliris J, Murphy L, Carmella SG, Han S, Link C, et al. 2003. Metabolites of a tobacco-specific lung carcinogen in nonsmoking casino patrons. Cancer Epidemiol Biomarkers Prev 12(12):1544-1546.
3. Athens-Clarke County, Georgia. Code of Ordinances, Section 4.3. July 5, 2005. Available: http://library.municode.com/index.aspx?clientId=12400&stateId=10&stateNa me=Georgia [accessed 7 June 2012].
4. Barnoya J, Glantz SA. 2005. Cardiovascular effects of secondhand smoke-nearly as large as smoking. Circulation 111(20):2684-2698.
5. Benowitz NL. 1996. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 18(2):188-204.
6. Benowitz NL. 1999. Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect 107:349-355.
7. Benowitz NL, Goniewicz M, Eisner M, Lazcano-Ponce E, Zielinska-Danch W, Koszowski B, et al. 2010. Urine cotinine underestimates exposure to tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in passive compared to active smokers. Cancer Epidemiol Biomarkers Prev 19(11):2795-2800.
8. Bernert JT, McGuffey JE, Morrison MA, Pirkle JL. 2000. Comparison of serum and salivary cotinine measurements by a sensitive high-performance liquid chromatography-tandem mass spectrometry method as an indicator of exposure to tobacco smoke among smokers and nonsmokers. JAnal Toxicol 24(5):333-339.
9. Bondy SJ, Zhang B, Kreiger N, Selby P, Benowitz N, Travis H, et al. 2009. Impact of an indoor smoking ban on bar workers' exposure to secondhand smoke. J Occup Environ Med 51(5):612-619.
10. CARB (California Air Resources Board). 2005. Appendix III. Proposed Identification of Environmental Tobacco Smoke as a Toxic Air Contaminant. Part A-Exposure Assessment. Available: http://www.arb.ca.gov/regact/ets2006/app3parta.pdf [accessed 6 November 2011].
11. Curvall M, Elwin CE, Kazemi-Vala E, Warholm C, Enzell C. 1990. The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. Eur J Clin Pharmacol 38(3):281-287.
12. DHHS (Department of Health and Human Services). 1986. The Health Consequences of Involuntary Smoking: A Report of the Surgeon General. Rockville, MD:Centers for Disease Control, Center for Health Promotion and Education, Office on Smoking and Health.
13. DHHS (Department of Health and Human Services). 2006. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, GA:Centers for Disease Control and Prevention, National Centers for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
14. Eisner MD, Katz PP, Yelin EH, Hammond SK, Blanc PD. 2001. Measurement of environmental tobacco smoke exposure among adults with asthma. Environ Health Perspect 109:809-814.
15. Fleiss JL. 1986. The Design and Analysis of Clinical Experiments. New York:John Wiley & Sons, Inc.
16. Flouris AD, Metsios GS, Carrillo AE, Jamurtas AZ, GourgoulianisK, Kiropoulos T, et al. 2009. Acute and short-term effects of
17. Friedman M. 1937. The use of ranks to avoid the assumption of normality implicit in the analysis of variance. J Am Stat Assoc 32(200):675-701.
18. Georgia Smoke-free Air Act. 2005. SB 90/AP. 148th Georgia General Assembly, Regular Session. Available: http://www1.legis.ga.gov/legis/2005_06/pdf/sb90.pdf [accessed 7June 2012].
19. Goniewicz ML, Eisner MD, Lazcano-Ponce E, Zielinska-DanchW, Koszowski B, Sobczak A, et al. 2011. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking. Nicotine Tobacco Res 13(3):202-208.
20. Goniewicz ML, Havel CM, Peng MW, Jacob P, Dempsey D, YuL, et al. 2009. Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Cancer Epidemiol Biomarkers Prev 18(12):3421-3425.
21. Hall J, Bernert J, Hall D, St. Helen G, Kudon L, Naeher L. 2009. Assessment of exposure to secondhand smoke at outdoor bars and family restaurants in Athens, Georgia, using salivary cotinine. J Occup Env Hyg 6(11):698-704.
22. Hecht SS. 1996. Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen. Crit Rev Toxicol 26(2):163-181.
23. Hecht SS. 2003. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 3:733-744.
24. Herman PM, Walsh ME. 2010. Hospital admissions for acute myocardial infarction, angina, stroke, and asthma after implementation of Arizona's comprehensive statewide smoking ban. Am J Public Health 101(3):491-496.
25. Hoffmann D, Hecht SS. 1990. Advances in tobacco carcinogenesis. In: Handbook of Environmental Pharmacology (Cooper CS, Grover PL, eds). New York:Springer-Verlag, 63-102.
26. Hoffmann D, Rivenson A, Hecht SS. 1996. The biological significance of tobacco-specific N-nitrosamines: smoking and adenocarcinoma of the lung. Crit Rev Toxicol 26(2):199-211.
27. Kaufman P, Zhang B, Bondy SJ, Klepeis N, Ferrence R. 2010. Not just "a few wisps": real-time measurement of tobacco smoke at entrances to office buildings. Tob Control 20(3):212-218.
28. Klepeis NE, Ott WR, Switzer P. 2007. Real-time measurement of outdoor tobacco smoke particles. J Air Waste Manage Assoc 57(5): 522-534.
29. Parsons WD, Carmella SG, Akerkar S, Bonilla LE, Hecht SS. 1998. A metabolite of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the urine of hospital workers exposed to environmental tobacco smoke. Cancer Epidemiol Biomarkers Prev 7(3):257-260.
30. Repace JL, Jinot J, Bayard S, Emmons K, Hammond SK. 1998. Air nicotine and saliva cotinine as indicators of workplace passive smoking exposure and risk. Risk Anal 18(1):71-83.
31. Schick SF, Glantz S. 2007. Concentrations of the carcinogen 4-(methyinitrosamino)1-(3-pyridyl)-1-butanone in sidestream cigarette smoke increase after release into indoor air: results from unpublished tobacco industry research. Cancer Epidemiol Biomarkers Prev 16(8):1547-1553.
32. 2.5) and carbon monoxide from secondhand smoke outside bars and restaurants in downtown Athens, Georgia. J Environ Health 74:8-11.
33. Stepanov I, Hecht SS. 2005. Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users. Cancer Epidemiol Biomarkers Prev 14(4):885-891.
34. Vineis P, Hoek G, Krzyzanowski M, Vigna-Taglianti F, Veglia F, Airoldi L, et al. 2007. Lung cancers attributable to environmental tobacco smoke and air pollution in non-smokers in different European countries: a prospective study. Environ Health 6(1): 7-13.
35. Xia Y, Bernert JT. 2010. Stability of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine samples stored at various temperatures. J Anal Toxicol 34(7):411-415.